Previous 10 | Next 10 |
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, announced the pricing of its previousl...
Baudax Bio (NASDAQ:BXRX) trades 21% down after hours on commencing a proposed underwritten public offering of shares and warrants. Underwriters to be be granted option to purchase additional shares and/or warrants at the public offering price. Offer size, terms have not yet bee...
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, announced it has commenced a proposed ...
Gainers: Creative Medical Technology (NASDAQ:CELZ) +33%. HOOKIPA Pharma (NASDAQ:HOOK) +18%. Zynex ZYXI +17%. AMN Healthcare Services (NYSE:AMN) +15%. ShockWave Medical (NASDAQ:SWAV) +10%. Losers: Baudax Bio (NASDAQ:BXRX) -11%. Nuvectis Pharma (NASDAQ:NVCT)...
Gainers: HOOKIPA Pharma (NASDAQ:HOOK) +55%. Upstart Holdings (NASDAQ:UPST) +32%. Eqonex (NASDAQ:EQOS) +19%. Singularity (NASDAQ:SGLY) +15%. Alkermes (NASDAQ:ALKS) +14%. Generac Holdings (NYSE:GNRC) +14%. MYT Netherlands (NYSE:MYTE) +12%. MRC Global (NYSE:MRC) +12%. NextDecade (NASDAQ:NEXT) +1...
Gainers: HOOKIPA Pharma (NASDAQ:HOOK) +46%. Kinnate Biopharma (NASDAQ:KNTE) +9%. Corcept Therapeutics (NASDAQ:CORT) +7%. Alkermes (NASDAQ:ALKS) +5%. Celularity (NASDAQ:CELU) +3%. Losers: Masimo (NASDAQ:MASI) -36%. Baudax Bio (NASDAQ:BXRX) -20%. ...
Roblox RBLX -17% on Q4 earnings. Baudax Bio (NASDAQ:BXRX) -15%. Toast TOST -15% on Q4 earnings. Wix.com WIX -14% on Q4 earnings. ViacomCBS VIAC -13% on Q4 earnings. Telefonaktiebolaget LM Ericsson (publ) (NASDAQ:ERIC) -12%. ZoomInfo Technologies ZI ...
Baudax Bio (NASDAQ:BXRX) announced that the company's board has approved a 1-for-35 reverse stock split of its common shares. The Reverse Stock Split will become effective on Feb.16 and the company's common stock will begin trading on The Nasdaq Capital Market on a post-split basis unde...
MALVERN, Pa., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that the Company’s Board of Directors has approved a 1-for-35 reverse stock s...
4 Penny Stocks to Add to Your Watchlist Right Now After a more than shaky week of trading for both penny stocks and blue chips, investors are excited to get another week up and going. But, to make money with penny stocks , traders need to do two things. First and foremost, investors...
News, Short Squeeze, Breakout and More Instantly...
Baudax Bio Inc. Company Name:
BXRX Stock Symbol:
NYSE Market:
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
Baudax Bio Inc. (BXRX) is expected to report $-0.53 for Q3 2023